Effect of Asian dust on respiratory symptoms among children with and without asthma, and their sensitivity

Hideki Hasunuma1, Ayano Takeuchi2, Rintaro Ono3

  • 1Department of Public Health, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan; Center for Environmental Information Science, 3-2-7 Kudan-minami, Chiyoda-ku, Tokyo, 102-0074, Japan.

Insights

Asian dust exposure significantly worsened respiratory symptoms in children with asthma not on preventive medication. Long-term asthma medication may protect against Asian dust effects, suggesting a potential preventive strategy.

Area of Science:

  • Environmental Health
  • Pediatric Respiratory Medicine
  • Epidemiology

Background:

  • Limited research exists on Asian dust exposure's impact on children's respiratory health.
  • Children are particularly vulnerable to environmental factors affecting respiratory well-being.

Purpose of the Study:

  • To investigate the association between Asian dust exposure and respiratory symptoms in children.
  • To examine differential effects based on asthma status and medication use.
  • To assess the role of individual sensitivity in respiratory aggravation.

Main Methods:

  • A panel study involving 137 schoolchildren and 23 children with asthma.
  • Data collection included peak expiratory flow rate (PEF) and daily symptom diaries.
  • Asian dust exposure assessed using Light Detection and Ranging (LIDAR) data; analysis employed case-crossover design and generalized estimating equation (GEE) models.

Main Results:

  • Children with asthma not on long-term preventive medication (CA) showed significant associations between Asian dust exposure and asthma-like symptoms (HR 5.17) and reduced %maxPEF.
  • Children without asthma exhibited a significant association between Asian dust exposure and reduced %maxPEF.
  • No adverse effects were observed in children with asthma on long-term preventive medication (CA-LTM).

Conclusions:

  • Long-term preventive asthma medication may mitigate respiratory symptom aggravation from Asian dust exposure.
  • Asian dust poses a risk for respiratory and nasal symptoms in children, particularly those with asthma not on preventive treatment.
  • Findings suggest the potential efficacy of long-term preventive medication as a protective measure against environmental respiratory triggers.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.2K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.1K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.9K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
745